Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Profound Medical Corp.
T.PRN
Alternate Symbol(s):
PROF
Healthcare
Medical Devices
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision...
-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:PRN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(17)
•••
HomerAndCompany
X
Post by
HomerAndCompany
on May 11, 2023 7:58am
Q1 2023 Financial Results - Recurring revenue up 43% YOY
..... Summary First Quarter 2023 Results For the quarter ended March 31, 2023, the Company recorded revenue of approximately $1.9 million, representing an increase of 36% from approximately $1.4
...more
(1124)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on May 04, 2023 6:53pm
not just one but two cantechletter.com articles
By Jayson MacLean Published on May 4, 2023 Last Updated on May 4, 2023 Filed under: All posts, Analysts, Life Sciences Stock: prof Profound Medical is still
...more
(7966)
•••
retiredcf
X
Post by
retiredcf
on Apr 25, 2023 11:45am
JF Tardif
Smart Money: Jean-Franois Tardif on which stocks to target when the market is going sideways Jean-Franois Tardif is laser-focused on making money when equity markets go nowhere. He buys compelling
...more
(1124)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Apr 11, 2023 11:53am
Raymond James - STRONG BUY -cantechletter.com
Profound Medical is a Strong Buy, says Raymond James By Jayson MacLean Published on April 11, 2023 Last Updated on April 11, 2023 Filed under: All posts
...more
(17)
•••
HomerAndCompany
X
Post by
HomerAndCompany
on Mar 17, 2023 10:43am
Keytruda fails more prostate and lung cancer PhIII trials
ENDPOINTSNEWS Feb 28: Merck's Keytruda fails more prostate trials:
(17)
•••
HomerAndCompany
X
Post by
HomerAndCompany
on Mar 17, 2023 9:08am
On cusp of exponential growth with 5% mo-over-mo rev growth?
2022 ended with 5% month-over-month revenue growth, that the company claims should be maintained or exceeded in 2023. Simple math (5% x 12) puts that at 60% growith for the year, but 5% compounded 12
...more
(17)
•••
HomerAndCompany
X
Post by
HomerAndCompany
on Mar 09, 2023 10:45am
@2022 end 5% month-over-month revenue increase from 35 sites
Latest quarter 2022 was all about growing recurring revenue with TULSA-PRO treatments in USA. The revenue growth rate reached 5% per month. No capital equipment sales last Q due to on-going COVID
...more
(1124)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Mar 08, 2023 8:48pm
Leede JOnes Gable - cantechletter.com
By Jayson MacLean Published on March 8, 2023 Last Updated on March 8, 2023 Filed under: All posts, Analysts, Health Stock: prof Still more upside to
...more
(17)
•••
HomerAndCompany
X
Post by
HomerAndCompany
on Mar 08, 2023 1:54pm
Profound Medical Announces Q4 and Full Year 2022 Financials
................ "Our U.S. TULSA business, both in terms of installed base growth and existing system utilization, has increasingly become the primary driver of our recurring revenue growth
...more
(60)
•••
snootchybootchy
X
Comment by
snootchybootchy
on Dec 14, 2022 6:14pm
RE:financing?
A financing would dilute shareholders and the share price would typically fall on such news. But let's say there is a financing in the works that would assuage shareholder concerns about the
...more
(3)
•••
rocko65
X
Post by
rocko65
on Dec 14, 2022 5:40pm
financing?
was my thought, either way nice to see things move in the right direction.
(60)
•••
snootchybootchy
X
Post by
snootchybootchy
on Dec 14, 2022 4:36pm
What's going on?
Stock has doubled in a week and nearly tripled in 7 weeks. Feels like T.PRN is getting acquired. One could surmise this is just a bounce from the bottom but there are lots of small/micro cap medical
...more
(243)
•••
homer111
X
Post by
homer111
on Nov 30, 2022 10:53am
Previous post
My apologies - my post was for another board, obviously....
(243)
•••
homer111
X
Post by
homer111
on Nov 30, 2022 10:51am
BB Credit Suisse 26th Annual Tech. Conference Transcript
https://seekingalpha.com/article/4561286-blackberry-limited-bb-credit-suisse-26th-annual-technology-conference-transcript Long read but very informative: BlackBerry Limited (NYSE:BB) Credit Suisse
...more
(17)
•••
HomerAndCompany
X
Comment by
HomerAndCompany
on Nov 25, 2022 9:01am
RE:RE:RE:Concerns over new ways to fight cancer
The share price was more than halved within 2 months of the Sept 2 press reslease in which they put off their applicaton for a permant "CPT" billing code until 2023. Delays in acquiring a
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Green Metals Royalty Company: "The Perfect Junior Mining Investment?" - Read More Here
Milestone Agreement for Developing Radiology Drugs Announced
Exclusive Insights on the Precious Metals Industry and What to Expect in 2023 – Download free report